Statistics on Biotechnology Use  
Results by sector of operation
Company sector.  Biotechnology results by main variables by whichever Biotechnology activities are the main ones, secondary or a tool necessary for production
Units: specified in variables

,Total,Main,Secondary dwellings,Tool,
Companies that carry out R&D in Biotechnology,1,133,603,173,357,
%Companies according to biotechnology used: Genetic code,33,39,28,25,
%Companies according to biotechnology used: Functional units,41,44,39,36,
%Companies according to biotechnology used: Cellular and tissue culturing and engineering,24,29,19,17,
%Companies according to biotechnology used: Bioprocesses,50,45,42,61,
%Companies according to biotechnology used: Sub-cellular organisms,6,8,5,3,
%Companies according to biotechnology used: Bio-computing,24,33,19,12,
%Companies according to biotechnology used: Nanobiotechnology,13,17,15,6,
%Companies according to biotechnology used: Other,14,16,16,11,
%Company by field(s) of ultimate application of biotechnology use: Human Health,45,59,41,24,
%Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture,18,21,14,13,
%Company by field(s) of ultimate application of biotechnology use: Food products,31,25,28,43,
%Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production,22,19,27,26,
%Company by field(s) of ultimate application of biotechnology use: Environment,14,11,22,13,
%Company by field(s) of ultimate application of biotechnology use: Industry,12,13,16,8,
Personnel in R&D in biotechnology (no. of persons),11,510,6,862,1,521,3,127,
Personnel in R&D in biotechnology (no. of persons): Researchers,6,202,3,759,900,1,543,
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants,5,308,3,103,621,1,584,
Personnel in R&D in biotechnology (no. of persons): women,6,389,4,015,750,1,624,
Personnel in R&D in biotechnology (no. of persons): (women) Researchers,3,304,2,079,442,783,
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants,3,086,1,937,308,841,
Personnel in R&D in biotechnology (FTE),8,236.9,5,430.2,989.7,1,817.0,
Personnel in R&D in biotechnology (FTE): Researchers,4,596.1,3,001.4,642.6,952.1,
Personnel in R&D in biotechnology (FTE): Technicians and assistants,3,640.8,2,428.8,347.1,864.9,
Personnel in R&D in biotechnology (FTE): women,4,698.5,3,180.1,503.1,1,015.3,
Personnel in R&D in biotechnology (FTE): (women) Researchers,2,512.5,1,684.7,323.4,504.4,
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants,2,186.0,1,495.4,179.7,510.9,
Internal expenditure on R&D (thousands of euros),769,431,541,881,63,951,163,599,
1) By nature of the expense: Current expenses,719,715,502,430,60,603,156,683,
1.1) Remuneration to researchers,221,447,151,282,26,154,44,011,
1.2) Remuneration to technicians and assistants,122,809,83,753,10,469,28,587,
1.3) Other current expenses,375,459,267,396,23,979,84,084,
2) By nature of the expense: Capital expenses,49,715,39,451,3,348,6,916,
2.1) Land and buildings,9,521,7,987,676,858,
2.2) Equipment and instruments,30,466,22,742,2,475,5,248,
2.3) Acquisition of specific R+D software,1,810,1,212,89,509,
2.4) Otros productos de propiedad intelectual específicos para I+D,7,919,7,510,108,301,
1.1) By origin of the funds: Own funds,490,913,347,382,40,321,103,210,
1.2) By origin of the funds: From companies,82,548,62,516,5,356,14,676,
1.3) By origin of the funds: Public Administration funds,96,809,67,645,12,905,16,259,
1.4) By origin of the funds: From Universities,197,193,0,4,
1.5) By origin of the funds: From non profit private institutions,4,766,1,422,0,3,344,
1.6) By origin of the funds: Foreign funds,94,197,62,723,5,369,26,106,
Purchase of R&D services in biotechnology (thousands of euros),120,281,102,804,9,714,7,763,
Purchase of R&D services in biotechnology (thousands of euros): In Spain,69,564,57,335,8,455,3,773,
Purchase of R&D services in biotechnology (thousands of euros): Abroad,50,718,45,469,1,259,3,990,
%Companies that consider the following obstacles as very important considering biotechnology development: Access to capital,45,52,42,35,
%Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information,12,9,17,16,
%Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources,16,14,20,18,
%Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain,14,14,16,12,
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of access to international markets,16,16,20,14,
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of distribution and sales channels,18,20,18,16,
%Companies that consider the following obstacles as very important considering biotechnology development : Acceptance / public perception,15,15,18,15,
%Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements,37,39,38,32,
%Companies that consider the following obstacles as very important considering biotechnology development : Time / cost,52,54,56,46,
%Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting,20,20,21,20,
% Companies that have requested biotechnology patents,15,21,11,7,
Number of patents requested,681,485,100,96,
% Companies with income of an international origin related to biotechnological activities,24.3,34.1,12.6,13.5,
% Turnover representing income of an international origin related to biotechnological activities,1.00,9.00,0.00,1.00,
% Income of of an international origin related to biotechnological activities distributed in: Income received from the EU,59.60,60.20,79.30,54.70,
% Income of of an international origin related to biotechnological activities distributed in: Income received from other countries,40.40,39.80,20.70,45.40,
% Income of of an international origin related to biotechnological activities by classification: Internacional trade in products and services,80.40,78.50,17.90,96.80,
% Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain,16.50,19.30,0.60,1.40,
% Income of an international origin related with activities according to the classification: Operating source abroad,2.20,1.30,70.40,1.80,
% Income of an international origin related with activities according to the classification: Other,0.90,0.90,11.10,0.00,
Notes:
1) '.'=numeric piece of data equal to zero not resulting from rounding 

 FTE: Full Time Equivalent
Source: National Statistics Institute